BioSpace News Archive

Biodexa Pharmaceuticals PLC announces that it has issued to various investors 6,218,265 new ordinary shares of £0.02 each in the Company, pursuant to exercise notices in respect of 1,243,653 B Warrants received yesterday.

Merck, known as MSD outside of the United States and Canada, will hold its first-quarter 2023 sales and earnings conference call with institutional investors and analysts at 9:00 a.m. ET on Thursday, April 27.

Novan, Inc., announced its financial and operating results for the full year ended December 31, 2022 and provided a corporate update.

Microbix Biosystems Inc., a life sciences innovator, manufacturer, and exporter, announces the voting results from the Annual and Special Meeting of Shareholders of the Company which was held on March 29, 2023.

Omega Therapeutics, Inc. (Nasdaq: OMGA) (“Omega”) today announced a clinical supply agreement with Roche to evaluate OTX-2002, its lead candidate in development for the treatment of MYC-driven hepatocellular carcinoma (HCC), in combination with Roche’s anti-PD-L1 therapy, atezolizumab, as part of Omega’s Phase 1/2 MYCHELANGELO™ I clinical trial.

Vivos Therapeutics, Inc. announced it plans to release its fourth quarter and full year 2022 financial results after market close, Thursday, March 30, 2023.

Confo Therapeutics announced that it has entered a collaboration agreement with Daiichi Sankyo for the discovery and development of small molecule agonists against an undisclosed target associated with CNS diseases.

Aptevo Therapeutics Inc. announced that the Company has raised $9.6 million in non-dilutive funding, extending its cash runway beyond 12 months with an additional $50,000 possible based on IXINITY sales in Q123.

Galectin Therapeutics, Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins, today reported financial results and provided a business update for the year ended December 31, 2022.

Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today reported financial results for the year ended December 31, 2022 and provided a company update.